Outset Medical, Inc. 8-K

What Happened
Outset Medical, Inc. filed an 8-K on February 11, 2026 announcing it issued a press release and will hold a conference call to report its fourth quarter and full year 2025 financial results for the period ended December 31, 2025. The company said it will also provide guidance for 2026 revenue and non‑GAAP gross margin. The press release is furnished as Exhibit 99.1 to the filing.

Key Details

• Filing date: February 11, 2026 (8-K, Item 2.02).
• Financial period reported: Quarter and year ended December 31, 2025.
• Forward-looking items: Company will provide 2026 revenue guidance and guidance for non‑GAAP gross margin.
• Exhibit included: Press release titled “Outset Medical Reports Fourth Quarter and Full Year 2025 Financial Results” (Exhibit 99.1). Filing signed by CFO Renee Gaeta.

Why It Matters
Investors should review the press release and listen to the earnings call for concrete revenue, profit and margin metrics and to update models. The 2026 revenue and non‑GAAP gross margin guidance will be key in assessing growth expectations and near‑term profitability trends for Outset Medical.